Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 10:19 am Sale | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital LP | 0 0.000% | -3,710,412 (Position Closed) | View |
| 2024-11-14 10:18 am Sale | 13G | Apogee Therapeutics Inc. APGE | Deep Track Capital LP | 1,000,000 2.220% | -1,323,456 (-56.96%) | View |
| 2024-11-14 10:00 am Sale | 13G | VIGIL NEUROSCIENCE INC VIGL | Deep Track Capital LP | 1,553,996 3.920% | -2,095,730 (-57.42%) | View |
| 2024-11-14 09:47 am Sale | 13G | Verona Pharma plc VRNA | Deep Track Capital LP | 25,440,200 3.910% | -7,492,192 (-22.75%) | View |
| 2024-11-14 09:46 am Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital LP | 531,857 0.700% | -6,990,424 (-92.93%) | View |
| 2024-11-14 09:45 am Sale | 13G | TOURMALINE BIO INC TRML | Deep Track Capital LP | 0 0.000% | -1,815,854 (Position Closed) | View |
| 2024-11-14 09:44 am Sale | 13G | Spyre Therapeutics Inc. SYRE | Deep Track Capital LP | 1,000,000 1.970% | -1,184,440 (-54.22%) | View |
| 2024-11-14 09:44 am Sale | 13G | Silence Therapeutics plc SLN | Deep Track Capital LP | 3,000,000 2.140% | -2,854,740 (-48.76%) | View |
| 2024-11-14 09:42 am Sale | 13G | REPARE THERAPEUTICS INC RPTX | Deep Track Capital LP | 0 0.000% | -2,992,731 (Position Closed) | View |
| 2024-11-14 09:41 am Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | Deep Track Capital LP | 674,833 2.240% | -1,369,674 (-66.99%) | View |
| 2024-11-14 09:39 am Sale | 13G | RAPT Therapeutics Inc. RAPT | Deep Track Capital LP | 0 0.000% | -1,793,966 (Position Closed) | View |
| 2024-11-14 09:38 am Sale | 13G | Orchard Therapeutics plc ORTX | Deep Track Capital LP | 0 0.000% | -19,125,150 (Position Closed) | View |
| 2024-11-14 09:36 am Sale | 13G | HILLEVAX INC HLVX | Deep Track Capital LP | 0 0.000% | -2,900,000 (Position Closed) | View |
| 2024-11-14 09:31 am Sale | 13G | GERON CORP GERN | Deep Track Capital LP | 7,575,049 1.260% | -22,008,400 (-74.39%) | View |
| 2024-11-14 09:29 am Sale | 13G | Climb Bio Inc. CLYM | Deep Track Capital LP | 2,169,143 3.230% | -1,735,642 (-44.45%) | View |
| 2024-11-14 09:27 am Purchase | 13G | Dyne Therapeutics Inc. DYN | Deep Track Capital LP | 3,282,000 3.270% | 1,282,000 (+64.10%) | View |
| 2024-11-14 09:24 am Sale | 13G | ANAPTYSBIO INC ANAB | Deep Track Capital LP | 0 0.000% | -2,036,990 (Position Closed) | View |
| 2024-11-14 09:21 am Sale | 13G | AGENUS INC AGEN | Deep Track Capital LP | 0 0.000% | -31,697,539 (Position Closed) | View |
| 2024-11-14 09:20 am Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | Deep Track Capital LP | 4,000,000 6.980% | 959,752 (+31.57%) | View |
| 2024-11-14 09:18 am Sale | 13G | NEKTAR THERAPEUTICS NKTR | Deep Track Capital LP | 15,922,655 8.650% | -2,477,345 (-13.46%) | View |